CC[C@]1(Cc2ccc(OC)c(OC)c2)C2CC(C(=O)OC)ON2O[C@H](OCc2ccccc2)[C@@H]1OC(C)=O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?